| Solid lipid nanoparticles – A promising drug delivery system H Svilenov, C Tzachev Nanomedicine 8, 187-237, 2014 | 86 | 2014 |
| Application of interpretable artificial neural networks to early monoclonal antibodies development L Gentiluomo, D Roessner, D Augustijn, H Svilenov, A Kulakova, ... European Journal of Pharmaceutics and Biopharmaceutics 141, 81-89, 2019 | 63 | 2019 |
| Isothermal chemical denaturation as a complementary tool to overcome limitations of thermal differential scanning fluorimetry in predicting physical stability of protein … H Svilenov, U Markoja, G Winter European Journal of Pharmaceutics and Biopharmaceutics 125, 106-113, 2018 | 60 | 2018 |
| Advancing therapeutic protein discovery and development through comprehensive computational and biophysical characterization L Gentiluomo, HL Svilenov, D Augustijn, I El Bialy, ML Greco, A Kulakova, ... Molecular Pharmaceutics 17 (2), 426-440, 2020 | 50 | 2020 |
| The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage H Svilenov, G Winter European Journal of Pharmaceutics and Biopharmaceutics 137, 131-139, 2019 | 38 | 2019 |
| Orthogonal Techniques to Study the Effect of pH, Sucrose, and Arginine Salts on Monoclonal Antibody Physical Stability and Aggregation During Long-term Storage HL Svilenov, A Kulakova, M Zalar, AP Golovanov, P Harris, G Winter Journal of pharmaceutical sciences 109 (1), 584-594, 2020 | 34 | 2020 |
| A new approach to study the physical stability of monoclonal antibody formulations - dilution from a denaturant H Svilenov, L Gentiluomo, W Friess, D Roessner, G Winter Journal of pharmaceutical sciences 107 (12), 3007-3013, 2018 | 28 | 2018 |
| Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins M Zalar, HL Svilenov, AP Golovanov European Journal of Pharmaceutics and Biopharmaceutics 151, 127-136, 2020 | 27 | 2020 |
| Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties HL Svilenov, P Arosio, T Menzen, P Tessier, P Sormanni MAbs 15 (1), 2164459, 2023 | 25 | 2023 |
| Modulated scanning fluorimetry can quickly assess thermal protein unfolding reversibility in microvolume samples HL Svilenov, T Menzen, K Richter, G Winter Molecular Pharmaceutics 17 (7), 2638–2647, 2020 | 24 | 2020 |
| Antibodies gone bad–the molecular mechanism of light chain amyloidosis RM Absmeier, GJ Rottenaicher, HL Svilenov, P Kazman, J Buchner The FEBS Journal 290 (6), 1398-1419, 2023 | 21 | 2023 |
| Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein HL Svilenov, J Sacherl, A Reiter, LS Wolff, CC Cheng, M Stern, V Grass, ... Antiviral Research 196, 105197, 2021 | 19 | 2021 |
| Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design HL Svilenov, J Sacherl, U Protzer, M Zacharias, J Buchner Nature Communications 12 (1), 6737, 2021 | 18 | 2021 |
| Rapid sample-saving biophysical characterisation and long-term storage stability of liquid interferon alpha2a formulations: Is there a correlation? H Svilenov, G Winter International Journal of Pharmaceutics 562, 42-50, 2019 | 18 | 2019 |
| Formulations that suppress aggregation during long-term storage of a bispecific antibody are characterized by high refoldability and colloidal stability HL Svilenov, G Winter Journal of Pharmaceutical Sciences 109 (6), 2048-2058, 2020 | 17 | 2020 |
| Structure-based discovery of a new protein-aggregation breaking excipient A Tosstorff, H Svilenov, GHJ Peters, P Harris, G Winter European Journal of Pharmaceutics and Biopharmaceutics 144, 207-216, 2019 | 15 | 2019 |
| Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies C Berner, T Menzen, G Winter, HL Svilenov Molecular Pharmaceutics 18 (6), 2242–2253, 2021 | 14 | 2021 |
| Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants HL Svilenov, R Bester, J Sacherl, R Absmeier, C Peters, U Protzer, ... Communications Biology 5 (1), 1237, 2022 | 13 | 2022 |
| Overcoming challenges in co-formulation of proteins with contradicting stability profiles-EPO plus G-CSF D Krieg, H Svilenov, JH Gitter, G Winter European Journal of Pharmaceutical Sciences 141, 105073, 2020 | 11 | 2020 |
| Efficient inhibition of SARS-CoV-2 strains by a novel ACE2-IgG4-Fc fusion protein with a stabilized hinge region HL Svilenov, J Sacherl, A Reiter, L Wolff, CC Chen, M Stern, FP Wachs, ... BioRxiv, 2020.12. 06.413443, 2020 | 8 | 2020 |
Gerhard WinterLMU MünchenПотвърден имейл адрес: cup.uni-muenchen.de